减肥神药每月1350美元降为350美元 GLP-1市场将从美国双寡头转向多维竞争

每日经济新闻
Nov 11

近期,礼来和诺和诺德与美国政府达成GLP-1减肥药大幅降价协议。根据上周公布的协议,联邦医疗保险(Medicare)和医疗补助计划(Medicaid)患者将能以每月245美元的标价获得礼来Zepbound和诺和诺德Wegovy等GLP-1药物,联邦医疗保险患者自付费用仅为50美元。  《每日经济新闻》记者注意到,诺和诺德高管在新闻发布会现场晕倒的小插曲,难掩协议本身的行业地震级影响。这是美国联邦...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10